Therapeia GmbH & Co. KG founded in Dresden (Germany) in the year 2007 has been dedicated to radiopharmaceutical development for the benefit of the patient and with the general aim to have a stake in the future of this promising modality of medical research.

The first development of ACD-101 consists of a family of products in the indication of malignant gliomas. You will find more information about this project on the website.

If you have general questions with regard to the company or if you are a researcher and have a promising project, please contact us using the details on the right side or our contact template.

Contact Therapeia

Therapeia GmbH & Co. KG
Veilchenweg 38
01326 Dresden

Tel: +49 (0)351 4188 00000
Fax: +49 (0)351 4188 00009


or just use our contact form




Programmierung: screenfox New Media - Kamenz

Hosting: FORMALITY Deutschland